
HIV Treatment Strategies in 2019 and Beyond
Target Audience
Learning Objectives
- Utilize current and emerging HIV therapies and treatment paradigms to improve their treatment of HIV-positive patients;
- Evaluate and apply criteria for evaluating current and emerging HIV therapies and treatment paradigms;
- Assess and discuss the latest data on HIV therapies and treatment paradigms;
- Compare and contrast major ARV guidelines recommendations with emerging HIV therapies and treatment paradigms and discuss the relative advantages and disadvantages;
- Discuss future directions in HIV treatment and research.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via email at [email protected].
The University of Chicago and ViralEd Inc. reserve the right to cancel or postpone this conference due to unforseen circumstance. In the unlikely event must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
FACULTY
Medical Director
Institute for Advanced Medicine
Mt. Sinai St. Luke’s and Mt. Sinai Roosevelt Hospitals
New York, New York
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and ViralEd, Inc. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Health Professions Credit
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.